Vikram Thermo (India) Ltd
Incorporated in 1985, Vikram Thermo
Ltd manufactures and sells basic pharma
co-polymers[1]
- Market Cap ₹ 528 Cr.
- Current Price ₹ 168
- High / Low ₹ 216 / 153
- Stock P/E 23.9
- Book Value ₹ 38.7
- Dividend Yield 0.45 %
- ROCE 36.3 %
- ROE 18.8 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Company has delivered good profit growth of 25.1% CAGR over last 5 years
- Company has been maintaining a healthy dividend payout of 19.1%
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Commodity Chemicals
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
42 | 37 | 38 | 45 | 49 | 58 | 56 | 74 | 93 | 112 | 126 | 126 | |
33 | 32 | 31 | 37 | 44 | 49 | 44 | 55 | 78 | 85 | 89 | 82 | |
Operating Profit | 9 | 5 | 8 | 8 | 5 | 9 | 12 | 18 | 15 | 26 | 38 | 45 |
OPM % | 22% | 15% | 20% | 19% | 10% | 15% | 21% | 25% | 16% | 23% | 30% | 35% |
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | -23 | |
Interest | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Depreciation | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 3 |
Profit before tax | 8 | 5 | 6 | 7 | 3 | 6 | 9 | 16 | 12 | 23 | 34 | 18 |
Tax % | 33% | 34% | 34% | 35% | 25% | 28% | 23% | 25% | 26% | 27% | 25% | 56% |
6 | 3 | 4 | 5 | 2 | 4 | 7 | 12 | 9 | 17 | 25 | 8 | |
EPS in Rs | 2.04 | 1.11 | 1.51 | 1.68 | 0.84 | 1.58 | 2.30 | 3.83 | 2.76 | 5.39 | 8.08 | 2.58 |
Dividend Payout % | 15% | 13% | 20% | 20% | 12% | 19% | 13% | 8% | 2% | 9% | 9% | 39% |
Compounded Sales Growth | |
---|---|
10 Years: | 13% |
5 Years: | 18% |
3 Years: | 11% |
TTM: | 0% |
Compounded Profit Growth | |
---|---|
10 Years: | 22% |
5 Years: | 25% |
3 Years: | 37% |
TTM: | -13% |
Stock Price CAGR | |
---|---|
10 Years: | 32% |
5 Years: | 59% |
3 Years: | 73% |
1 Year: | -9% |
Return on Equity | |
---|---|
10 Years: | 17% |
5 Years: | 20% |
3 Years: | 21% |
Last Year: | 19% |
Balance Sheet
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 31 | 31 | 31 |
Reserves | 21 | 23 | 27 | 32 | 33 | 37 | 48 | 59 | 67 | 58 | 82 | 90 |
2 | 4 | 1 | 6 | 12 | 14 | 6 | 10 | 15 | 19 | 7 | 6 | |
8 | 8 | 8 | 10 | 9 | 9 | 13 | 16 | 16 | 19 | 22 | 18 | |
Total Liabilities | 36 | 41 | 41 | 53 | 60 | 66 | 73 | 92 | 104 | 127 | 143 | 146 |
9 | 10 | 17 | 21 | 30 | 34 | 34 | 32 | 53 | 61 | 61 | 45 | |
CWIP | 7 | 9 | 1 | 7 | 4 | 0 | 6 | 18 | 0 | 0 | 1 | 0 |
Investments | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 10 | 11 | 11 | 15 | 0 |
20 | 22 | 22 | 25 | 26 | 32 | 32 | 32 | 40 | 55 | 65 | 101 | |
Total Assets | 36 | 41 | 41 | 53 | 60 | 66 | 73 | 92 | 104 | 127 | 143 | 146 |
Cash Flows
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
5 | 2 | 2 | 6 | 3 | 4 | 13 | 15 | 6 | 13 | 23 | 24 | |
-4 | -3 | -1 | -10 | -8 | -2 | -10 | -19 | -7 | -13 | -9 | -22 | |
-1 | 1 | -4 | 4 | 4 | 1 | -4 | 3 | 3 | 1 | -14 | -4 | |
Net Cash Flow | 0 | -0 | -2 | -0 | -0 | 3 | -1 | -1 | 1 | 2 | -0 | -3 |
Ratios
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 95 | 131 | 139 | 115 | 139 | 138 | 129 | 99 | 93 | 109 | 114 | 128 |
Inventory Days | 62 | 64 | 64 | 98 | 60 | 53 | 97 | 94 | 74 | 64 | 92 | 76 |
Days Payable | 84 | 84 | 81 | 102 | 70 | 52 | 107 | 92 | 62 | 69 | 80 | 74 |
Cash Conversion Cycle | 72 | 111 | 123 | 111 | 128 | 139 | 119 | 101 | 106 | 104 | 126 | 130 |
Working Capital Days | 82 | 120 | 147 | 124 | 120 | 121 | 102 | 81 | 92 | 98 | 110 | 134 |
ROCE % | 33% | 16% | 20% | 19% | 8% | 14% | 17% | 24% | 15% | 25% | 31% | 36% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
27 May - Copy of advertisement given in newspaper of audited financial results for the quarter and year ended 31-03-2025 in compliance of Reg. 47 of SEBI (LODR) …
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
26 May - Annual Secretarial Compliance Report for FY 2024-25 with minor website update non-compliance noted.
-
Announcement under Regulation 30 (LODR)-Change in Management
26 May - Approved FY25 results, 10% final dividend, new CFO appointed, auditor appointments, 10% salary hikes for key executives.
-
Integrated Filing (Financial)
26 May - Audited Q4 and FY25 results: Rs.841.77L net profit post Rs.2534L exceptional demerger loss; 10% dividend recommended.
-
COMPLIANCE OF REGULATION 33 OF SEBI (LISTING OBLIGATIONS AND DISCLOSURES REQUIREMENTS) REGULATIONS, 2015 FOR M/S. VIKRAM THERMO (INDIA) LIMITED.
26 May - Vikram Thermo reports FY25 audited results: Rs.12,623L revenue, Rs.841.77L PAT, Rs.2,534L exceptional loss on demerger.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Business Overview:[1]
VTL is an ISO 9001, DRCOAT and
EXCiPACT International GMP certified integrated, research-based pharmaceutical excipient company. It manufactures, markets, and exports pharmaceutical excipients and chemicals.